{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:56:06Z","timestamp":1782021366805,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["UNIVERSAL 449984\/2014-1"],"award-info":[{"award-number":["UNIVERSAL 449984\/2014-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["UNIVERSAL 446997\/2014-5"],"award-info":[{"award-number":["UNIVERSAL 446997\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["EDITAL APQ-00557-14"],"award-info":[{"award-number":["EDITAL APQ-00557-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00705-017-3641-5","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T13:17:30Z","timestamp":1510838250000},"page":"575-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacophoric characteristics of dengue virus NS2B\/NS3pro inhibitors: a systematic review of the most promising compounds"],"prefix":"10.1007","volume":"163","author":[{"given":"Camyla Alves","family":"Leonel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Gustavo","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelli","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane Coelho","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Gutterres","family":"Taranto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"de Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Lara","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline Maria Siqueira","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"3641_CR1","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/aps.2015.56","volume":"36","author":"D Wu","year":"2015","unstructured":"Wu D, Mao F, Ye Y et al (2015) Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Acta Pharmacol Sin 36:1126\u20131136. https:\/\/doi.org\/10.1038\/aps.2015.56","journal-title":"Acta Pharmacol Sin"},{"key":"3641_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","volume":"385","author":"MG Guzman","year":"2015","unstructured":"Guzman MG, Harris E (2015) Dengue. Lancet 385:453\u2013465. https:\/\/doi.org\/10.1016\/S0140-6736(14)60572-9","journal-title":"Lancet"},{"key":"3641_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ et al (2013) The global distribution and burden of dengue. Nature 496:504\u2013507. https:\/\/doi.org\/10.1038\/nature12060","journal-title":"Nature"},{"key":"3641_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/embor.2011.84","volume":"12","author":"I Iturbe-Ormaetxe","year":"2011","unstructured":"Iturbe-Ormaetxe I, Walker T, O\u2019 Neill SL (2011) Wolbachia and the biological control of mosquito-borne disease. EMBO Rep 12:508\u2013518. https:\/\/doi.org\/10.1038\/embor.2011.84","journal-title":"EMBO Rep"},{"key":"3641_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4149\/av_2016_01_3","volume":"60","author":"J Martin","year":"2016","unstructured":"Martin J, Hermida L (2016) Dengue vaccine: an update on recombinant subunit strategies. Acta Virol 60:3\u201314. https:\/\/doi.org\/10.4149\/av_2016_01_3","journal-title":"Acta Virol"},{"key":"3641_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1261770","author":"J Torresi","year":"2017","unstructured":"Torresi J, Ebert G, Pellegrini M (2017) Vaccines licensed and in clinical trials for the prevention of dengue. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2016.1261770","journal-title":"Hum Vaccin Immunother"},{"key":"3641_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2010.04.007","volume":"87","author":"M McDowell","year":"2010","unstructured":"McDowell M, Gonzales SR, Kumarapperuma SC et al (2010) A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1, 2, 4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. Antivir Res 87:78\u201380. https:\/\/doi.org\/10.1016\/j.antiviral.2010.04.007","journal-title":"Antivir Res"},{"key":"3641_CR8","first-page":"1","volume-title":"Global strategy for dengue prevention and control 2012\u20132020","author":"World Health Organization","year":"2012","unstructured":"World Health Organization (2012) Global strategy for dengue prevention and control 2012\u20132020. WHO, Geneva, pp 1\u201343"},{"key":"3641_CR9","doi-asserted-by":"publisher","first-page":"e0003749","DOI":"10.1371\/journal.pntd.0003749","volume":"9","author":"J Flipse","year":"2015","unstructured":"Flipse J, Smit JM (2015) The complexity of a dengue vaccine: a review of the human antibody response. PLoS Negl Trop Dis 9:e0003749. https:\/\/doi.org\/10.1371\/journal.pntd.0003749","journal-title":"PLoS Negl Trop Dis"},{"key":"3641_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1590\/S1415-47572010000200002","volume":"33","author":"S Natarajan","year":"2010","unstructured":"Natarajan S (2010) NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus. Genet Mol Biol 33:214\u2013219. https:\/\/doi.org\/10.1590\/S1415-47572010000200002","journal-title":"Genet Mol Biol"},{"key":"3641_CR11","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/jvi.62.8.3027-3031.1988","volume":"62","author":"YM Zhang","year":"1988","unstructured":"Zhang YM, Hayes EP, McCarty TC et al (1988) Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J Virol 62:3027\u20133031","journal-title":"J Virol"},{"key":"3641_CR12","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1128\/JVI.01257-06","volume":"80","author":"K Clyde","year":"2006","unstructured":"Clyde K, Kyle JL, Harris E (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80:11418\u201311431. https:\/\/doi.org\/10.1128\/jvi.01257-06","journal-title":"J Virol"},{"key":"3641_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1743-422X-2-64","volume":"2","author":"CM Fauquet","year":"2005","unstructured":"Fauquet CM, Fargette D (2005) International Committee on Taxonomy of Viruses and the 3,142 unassigned species. Virol J 2:64. https:\/\/doi.org\/10.1186\/1743-422X-2-64","journal-title":"Virol J"},{"key":"3641_CR14","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","volume":"79","author":"T Xu","year":"2005","unstructured":"Xu T, Sampath A, Chao A et al (2005) Structure of the dengue virus helicase\/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J Virol 79:10278\u201310288. https:\/\/doi.org\/10.1128\/JVI.79.16.10278-10288.2005","journal-title":"J Virol"},{"key":"3641_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"TJ Chambers","year":"1990","unstructured":"Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649\u2013688. https:\/\/doi.org\/10.1146\/annurev.mi.44.100190.003245","journal-title":"Annu Rev Microbiol"},{"key":"3641_CR16","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","volume":"65","author":"B Falgout","year":"1991","unstructured":"Falgout B, Pethel M, Zhang YM, Lai CJ (1991) Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 65:2467\u20132475","journal-title":"J Virol"},{"key":"3641_CR17","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JVI.72.3.2141-2149.1998","volume":"72","author":"CE Stocks","year":"1998","unstructured":"Stocks CE, Lobigs M (1998) Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J Virol 72:2141\u20132149","journal-title":"J Virol"},{"key":"3641_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","volume":"80","author":"J Lescar","year":"2008","unstructured":"Lescar J, Luo D, Xu T et al (2008) Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target. Antivir Res 80:94\u2013101. https:\/\/doi.org\/10.1016\/j.antiviral.2008.07.001","journal-title":"Antivir Res"},{"key":"3641_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pep.2017.07.002","volume":"140","author":"E Woestenenk","year":"2017","unstructured":"Woestenenk E, Agback P, Unnerst\u00e5le S et al (2017) Co-refolding of a functional complex of dengue NS3 protease and NS2B co-factor domain and backbone resonance assignment by solution NMR. Protein Expr Purif 140:16\u201327. https:\/\/doi.org\/10.1016\/j.pep.2017.07.002","journal-title":"Protein Expr Purif"},{"key":"3641_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.03.107","author":"D Aguilera-Pesantes","year":"2017","unstructured":"Aguilera-Pesantes D, Robayo LE, M\u00e9ndez PE et al (2017) Discovering key residues of dengue virus NS2b-NS3-protease: new binding sites for antiviral inhibitors design. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.107","journal-title":"Biochem Biophys Res Commun"},{"key":"3641_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1110\/ps.072753207","volume":"16","author":"AE Aleshin","year":"2007","unstructured":"Aleshin AE, Shiryaev SA, Strongin AY, Liddington RC (2007) Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci 16:795\u2013806. https:\/\/doi.org\/10.1110\/ps.072753207","journal-title":"Protein Sci"},{"key":"3641_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nsmb1073","volume":"13","author":"P Erbel","year":"2006","unstructured":"Erbel P, Schiering N, D\u2019Arcy A et al (2006) Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 13:372\u2013373. https:\/\/doi.org\/10.1038\/nsmb1073","journal-title":"Nat Struct Mol Biol"},{"key":"3641_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.pep.2015.11.022","volume":"119","author":"AE Shannon","year":"2016","unstructured":"Shannon AE, Chappell KJ, Stoermer MJ et al (2016) Simultaneous uncoupled expression and purification of the dengue virus NS3 protease and NS2B co-factor domain. Protein Expr Purif 119:124\u2013129. https:\/\/doi.org\/10.1016\/j.pep.2015.11.022","journal-title":"Protein Expr Purif"},{"key":"3641_CR24","doi-asserted-by":"publisher","DOI":"10.21577\/0103-5053.20160242","author":"IP God\u00f3i","year":"2016","unstructured":"God\u00f3i IP, Lima WG, Junior MC, Jos\u00e9 R (2016) Docking and QM\/MM studies of NS2B-NS3pro inhibitors: a molecular target against the dengue virus. J Braz Chem Soc. https:\/\/doi.org\/10.21577\/0103-5053.20160242","journal-title":"J Braz Chem Soc"},{"key":"3641_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","volume":"119","author":"SP Lim","year":"2015","unstructured":"Lim SP, Noble CG, Shi P-Y et al (2015) The dengue virus NS5 protein as a target for drug discovery. Antivir Res 119:57\u201367. https:\/\/doi.org\/10.1016\/j.antiviral.2015.04.010","journal-title":"Antivir Res"},{"key":"3641_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/v9040091","author":"A El Sahili","year":"2017","unstructured":"El Sahili A, Lescar J (2017) Dengue virus non-structural protein 5. Viruses. https:\/\/doi.org\/10.3390\/v9040091","journal-title":"Viruses"},{"key":"3641_CR27","doi-asserted-by":"publisher","first-page":"e1005841","DOI":"10.1371\/journal.ppat.1005841","volume":"12","author":"FA De Maio","year":"2016","unstructured":"De Maio FA, Risso G, Iglesias NG et al (2016) The dengue virus NS5 protein intrudes in the cellular spliceosome and modulates splicing. PLoS Pathog 12:e1005841. https:\/\/doi.org\/10.1371\/journal.ppat.1005841","journal-title":"PLoS Pathog"},{"key":"3641_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/13543784.2016.1212837","volume":"25","author":"NM Midde","year":"2016","unstructured":"Midde NM, Patters BJ, Rao PSS et al (2016) Investigational protease inhibitors as antiretroviral therapies. Expert Opin Investig Drugs 25:1189\u20131200. https:\/\/doi.org\/10.1080\/13543784.2016.1212837","journal-title":"Expert Opin Investig Drugs"},{"key":"3641_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10822-010-9326-8","volume":"24","author":"V Frecer","year":"2010","unstructured":"Frecer V, Miertus S (2010) Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of dengue virus NS2B-NS3 protease. J Comput Aided Mol Des 24:195\u2013212. https:\/\/doi.org\/10.1007\/s10822-010-9326-8","journal-title":"J Comput Aided Mol Des"},{"key":"3641_CR30","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1016\/j.bmcl.2017.05.027","volume":"27","author":"Y Takagi","year":"2017","unstructured":"Takagi Y, Matsui K, Nobori H et al (2017) Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity. Bioorg Med Chem Lett 27:3586\u20133590. https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.027","journal-title":"Bioorg Med Chem Lett"},{"key":"3641_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11262-011-0709-2","volume":"44","author":"P Rodpothong","year":"2012","unstructured":"Rodpothong P, Auewarakul P (2012) Positive selection sites in the surface genes of dengue virus: phylogenetic analysis of the interserotypic branches of the four serotypes. Virus Genes 44:408\u2013414. https:\/\/doi.org\/10.1007\/s11262-011-0709-2","journal-title":"Virus Genes"},{"key":"3641_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2013.09.078","volume":"440","author":"S Pambudi","year":"2013","unstructured":"Pambudi S, Kawashita N, Phanthanawiboon S et al (2013) A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication. Biochem Biophys Res Commun 440:393\u2013398. https:\/\/doi.org\/10.1016\/j.bbrc.2013.09.078","journal-title":"Biochem Biophys Res Commun"},{"key":"3641_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/1871526510909030327","volume":"9","author":"SM Tomlinson","year":"2009","unstructured":"Tomlinson SM, Malmstrom RD, Watowich SJ (2009) New approaches to structure-based discovery of dengue protease inhibitors. Infect Disord Drug Targets 9:327\u2013343. https:\/\/doi.org\/10.2174\/1871526510909030327","journal-title":"Infect Disord Drug Targets"},{"key":"3641_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/AAC.00855-10","volume":"55","author":"C-C Yang","year":"2011","unstructured":"Yang C-C, Hsieh Y-C, Lee S-J et al (2011) Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agents Chemother 55:229\u2013238","journal-title":"Antimicrob Agents Chemother"},{"key":"3641_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2180-14-140","volume":"14","author":"HA Rothan","year":"2014","unstructured":"Rothan HA, Bahrani H, Rahman NA, Yusof R (2014) Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol 14:140. https:\/\/doi.org\/10.1186\/1471-2180-14-140","journal-title":"BMC Microbiol"},{"key":"3641_CR36","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.03543-14","volume":"59","author":"H Wu","year":"2015","unstructured":"Wu H, Bock S, Snitko M et al (2015) Novel dengue virus NS2B\/NS3 protease inhibitors. Antimicrob Agents Chemother 59:1100\u20131109. https:\/\/doi.org\/10.1128\/AAC.03543-14","journal-title":"Antimicrob Agents Chemother"},{"key":"3641_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2016.08.014","volume":"134","author":"A Balasubramanian","year":"2016","unstructured":"Balasubramanian A, Manzano M, Teramoto T et al (2016) High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antivir Res 134:6\u201316. https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.014","journal-title":"Antivir Res"},{"key":"3641_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/AAC.01281-13","volume":"58","author":"C-C Yang","year":"2014","unstructured":"Yang C-C, Hu H-S, Wu R-H et al (2014) A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B\/NS3 protease. Antimicrob Agents Chemother 58:110\u2013119. https:\/\/doi.org\/10.1128\/AAC.01281-13","journal-title":"Antimicrob Agents Chemother"},{"key":"3641_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7150\/ijbs.6.294","volume":"6","author":"M Muhamad","year":"2010","unstructured":"Muhamad M, Kee LY, Rahman NA, Yusof R (2010) Antiviral actions of flavanoid-derived compounds on dengue virus type-2. Int J Biol Sci 6:294\u2013302. https:\/\/doi.org\/10.7150\/ijbs.6.294","journal-title":"Int J Biol Sci"},{"key":"3641_CR40","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1021\/jm900776m","volume":"53","author":"M Podvinec","year":"2010","unstructured":"Podvinec M, Lim SP, Schmidt T et al (2010) Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid. J Med Chem 53:1483\u20131495. https:\/\/doi.org\/10.1021\/jm900776m","journal-title":"J Med Chem"},{"key":"3641_CR41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11030-010-9291-0","volume":"15","author":"K-H Altmann","year":"2011","unstructured":"Altmann K-H, Gaugaz FZ, Schiess R (2011) Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives. Mol Divers 15:383\u2013399. https:\/\/doi.org\/10.1007\/s11030-010-9291-0","journal-title":"Mol Divers"},{"key":"3641_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0732-8893(97)00004-7","volume":"28","author":"ME Erwin","year":"1997","unstructured":"Erwin ME, Varnam D, Jones RN (1997) In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin. Diagn Microbiol Infect Dis 28:93\u2013100. https:\/\/doi.org\/10.1016\/S0732-8893(97)00004-7","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3641_CR43","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1016\/j.bmc.2005.12.039","volume":"14","author":"C Maurin","year":"2006","unstructured":"Maurin C, Bailly F, Mbemba G et al (2006) Design, synthesis, and anti-integrase activity of catechol-DKA hybrids. Bioorg Med Chem 14:2978\u20132984. https:\/\/doi.org\/10.1016\/j.bmc.2005.12.039","journal-title":"Bioorg Med Chem"},{"key":"3641_CR44","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00726-009-0353-5","volume":"38","author":"F Hoegy","year":"2010","unstructured":"Hoegy F, Gwynn MN, Schalk IJ (2010) Susceptibility of Pseudomonas aeruginosa to catechol-substituted cephalosporin is unrelated to the pyochelin-Fe transporter FptA. Amino Acids 38:1627\u20131629. https:\/\/doi.org\/10.1007\/s00726-009-0353-5","journal-title":"Amino Acids"},{"key":"3641_CR45","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1016\/j.bmc.2013.10.026","volume":"21","author":"T Bozzini","year":"2013","unstructured":"Bozzini T, Botta G, Delfino M et al (2013) Tyrosinase and layer-by-layer supported tyrosinases in the synthesis of lipophilic catechols with antiinfluenza activity. Bioorg Med Chem 21:7699\u20137708. https:\/\/doi.org\/10.1016\/j.bmc.2013.10.026","journal-title":"Bioorg Med Chem"},{"key":"3641_CR46","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/cmdc.201600015","volume":"11","author":"A Corona","year":"2016","unstructured":"Corona A, Desantis J, Massari S et al (2016) Studies on cycloheptathiophene-3-carboxamide derivatives as allosteric HIV-1 ribonuclease H inhibitors. Chem Med Chem 11:1709\u20131720. https:\/\/doi.org\/10.1002\/cmdc.201600015","journal-title":"Chem Med Chem"},{"key":"3641_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/jac\/dkv402","volume":"71","author":"A Ito","year":"2016","unstructured":"Ito A, Kohira N, Bouchillon SK et al (2016) In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria. J Antimicrob Chemother 71:670\u2013677. https:\/\/doi.org\/10.1093\/jac\/dkv402","journal-title":"J Antimicrob Chemother"},{"key":"3641_CR48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/JVI.72.1.624-632.1998","volume":"72","author":"RPC Valle","year":"1998","unstructured":"Valle RPC, Falgout B (1998) Mutagenesis of the NS3 protease of dengue virus type 2. J Virol 72:624\u2013632","journal-title":"J Virol"},{"key":"3641_CR49","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.ejmech.2010.03.002","volume":"45","author":"D Kumar","year":"2010","unstructured":"Kumar D, Judge V, Narang R et al (2010) Benzylidene\/2-chlorobenzylidene hydrazides: synthesis, antimicrobial activity, QSAR studies and antiviral evaluation. Eur J Med Chem 45:2806\u20132816. https:\/\/doi.org\/10.1016\/j.ejmech.2010.03.002","journal-title":"Eur J Med Chem"},{"key":"3641_CR50","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.ejmech.2008.09.029","volume":"44","author":"BF Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM (2009) Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem 44:2632\u20132635. https:\/\/doi.org\/10.1016\/j.ejmech.2008.09.029","journal-title":"Eur J Med Chem"},{"key":"3641_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3329\/bjm.v23i2.872","volume":"23","author":"N Sharmin","year":"2006","unstructured":"Sharmin N (2006) Computational analyses of NS3 serine protease of dengue virus. Bangladesh J Microbiol 23:107\u2013113. https:\/\/doi.org\/10.3329\/bjm.v23i2.872","journal-title":"Bangladesh J Microbiol"},{"key":"3641_CR52","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/etc.3446","volume":"35","author":"CI Olivares","year":"2016","unstructured":"Olivares CI, Sierra-Alvarez R, Abrell L et al (2016) Zebrafish embryo toxicity of anaerobic biotransformation products from the insensitive munitions compound 2,4-dinitroanisole. Environ Toxicol Chem 35:2774\u20132781. https:\/\/doi.org\/10.1002\/etc.3446","journal-title":"Environ Toxicol Chem"},{"key":"3641_CR53","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.2174\/138161211798194512","volume":"17","author":"MC Chin","year":"2011","unstructured":"Chin MC, Bosquesi PL, Santos JL (2011) A prodrug approach to improve the physico-chemical properties and decrease the genotoxicity of nitro compounds. Curr Pharm Des 17:3515\u20133526. https:\/\/doi.org\/10.2174\/138161211798194512","journal-title":"Curr Pharm Des"},{"key":"3641_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5433\/2316-5200.2014v3n2p16","volume":"3","author":"IP God\u00f3i","year":"2014","unstructured":"God\u00f3i IP, Taranto MFR, Lima WG et al (2014) NS2B-NS3pro as a molecular target drugs development against dengue (in Portuguese). BBR Biochem Biotechnol Rep 3:16\u201330","journal-title":"BBR Biochem Biotechnol Rep"},{"key":"3641_CR55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.33073\/pjm-2010-007","volume":"59","author":"B Brycki","year":"2010","unstructured":"Brycki B, Dega-Szafran Z, Mirska I, Mirska I (2010) Synthesis and antimicrobial activities of some quaternary morpholinium chlorides. Pol J Microbiol 59:49\u201353","journal-title":"Pol J Microbiol"},{"key":"3641_CR56","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bmc.2016.01.006","volume":"24","author":"O Soukup","year":"2016","unstructured":"Soukup O, Dolezal R, Malinak D et al (2016) Synthesis, antimicrobial evaluation and molecular modeling of 5-hydroxyisoquinolinium salt series; the effect of the hydroxyl moiety. Bioorg Med Chem 24:841\u2013848. https:\/\/doi.org\/10.1016\/j.bmc.2016.01.006","journal-title":"Bioorg Med Chem"},{"key":"3641_CR57","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2174\/138161213804805711","volume":"19","author":"M Kr\u00e1tk\u00fd","year":"2013","unstructured":"Kr\u00e1tk\u00fd M, Vinsova J (2013) Antimycobacterial activity of quaternary pyridinium salts and pyridinium N-oxides-review. Curr Pharm Des 19:1343\u20131355. https:\/\/doi.org\/10.2174\/138161213804805711","journal-title":"Curr Pharm Des"},{"key":"3641_CR58","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1016\/j.bmc.2013.08.014","volume":"21","author":"AS Sokolova","year":"2013","unstructured":"Sokolova AS, Yarovaya OI, Shernyukov AV et al (2013) New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity. Bioorg Med Chem 21:6690\u20136698. https:\/\/doi.org\/10.1016\/j.bmc.2013.08.014","journal-title":"Bioorg Med Chem"},{"key":"3641_CR59","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1128\/AEM.07738-11","volume":"78","author":"E Tuladhar","year":"2012","unstructured":"Tuladhar E, de Koning MC, Fundeanu I et al (2012) Different virucidal activities of hyperbranched quaternary ammonium coatings on poliovirus and influenza virus. Appl Environ Microbiol 78:2456\u20132458. https:\/\/doi.org\/10.1128\/AEM.07738-11","journal-title":"Appl Environ Microbiol"},{"key":"3641_CR60","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1016\/j.bmcl.2012.06.031","volume":"22","author":"AK Purohit","year":"2012","unstructured":"Purohit AK, Balish MD, Leichty JJ et al (2012) Antiviral activity and synthesis of quaternized promazine derivatives against HSV-1. Bioorg Med Chem Lett 22:5308\u20135312. https:\/\/doi.org\/10.1016\/j.bmcl.2012.06.031","journal-title":"Bioorg Med Chem Lett"},{"key":"3641_CR61","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1743-422X-6-187","volume":"6","author":"M Aljofan","year":"2009","unstructured":"Aljofan M, Sganga ML, Lo MK et al (2009) Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro. Virol J 6:187. https:\/\/doi.org\/10.1186\/1743-422X-6-187","journal-title":"Virol J"},{"key":"3641_CR62","first-page":"67","volume":"3","author":"S Baron","year":"1988","unstructured":"Baron S, Sabados J, McKerlie ML, Coppenhaver DH (1988) Antiviral activity in urine is attributable to ammonium salts. J Biol Regul Homeost Agents 3:67\u201370","journal-title":"J Biol Regul Homeost Agents"},{"key":"3641_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/cpt1977214457","volume":"21","author":"JHG Jonkman","year":"1977","unstructured":"Jonkman JHG, Van Bork LE, Wijsbeek J et al (1977) Variations in the bioavailability of thiazinamium methylsulfate. Clin Pharmacol Ther 21:457\u2013463. https:\/\/doi.org\/10.1002\/cpt1977214457","journal-title":"Clin Pharmacol Ther"},{"key":"3641_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb10085.x","author":"J Janhg","year":"1974","unstructured":"Janhg J, Wijsbeek J, Brouwer SH, Zeeuw RA (1974) Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration. J Pharm Pharmacol. https:\/\/doi.org\/10.1111\/j.2042-7158.1974.tb10085.x","journal-title":"J Pharm Pharmacol"},{"key":"3641_CR65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jchromb.2016.07.006","volume":"1029","author":"Y Li","year":"2016","unstructured":"Li Y, Liu X-G, Wang H-Y et al (2016) Pharmacokinetic studies of phellodendrine in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography\u2013tandem mass spectrometry. J Chromatogr B 1029:95\u2013101. https:\/\/doi.org\/10.1016\/j.jchromb.2016.07.006","journal-title":"J Chromatogr B"},{"key":"3641_CR66","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1152\/physrev.1965.45.3.523","volume":"45","author":"DB Taylor","year":"1965","unstructured":"Taylor DB, Nedergaard OA (1965) Relation between structure and action of quaternary ammonium neuromuscular blocking agents. Physiol Rev 45:523\u2013554","journal-title":"Physiol Rev"},{"key":"3641_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.12711","author":"Z Rao","year":"2016","unstructured":"Rao Z, Hu H, Tang J et al (2016) Steroidal ammonium compounds as new neuromuscular blocking agents. Chem Biol Drug Des. https:\/\/doi.org\/10.1111\/cbdd.12711","journal-title":"Chem Biol Drug Des"},{"key":"3641_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/bit.26066","volume":"114","author":"JL Guerrero","year":"2017","unstructured":"Guerrero JL, Daugherty PS, O\u2019Malley MA (2017) Emerging technologies for protease engineering: new tools to clear out disease. Biotechnol Bioeng 114:33\u201338. https:\/\/doi.org\/10.1002\/bit.26066","journal-title":"Biotechnol Bioeng"},{"key":"3641_CR69","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.2174\/0929867323666160510122525","volume":"23","author":"T Pillaiyar","year":"2016","unstructured":"Pillaiyar T, Namasivayam V, Manickam M (2016) Macrocyclic hepatitis C virus NS3\/4A protease inhibitors: an overview of medicinal chemistry. Curr Med Chem 23:3404\u20133447. https:\/\/doi.org\/10.2174\/0929867323666160510122525","journal-title":"Curr Med Chem"},{"key":"3641_CR70","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","volume":"58","author":"MAM Behnam","year":"2015","unstructured":"Behnam MAM, Graf D, Bartenschlager R et al (2015) Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue. J Med Chem 58:9354\u20139370. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01441","journal-title":"J Med Chem"},{"key":"3641_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2014.01.011","volume":"104","author":"X Zu","year":"2014","unstructured":"Zu X, Liu Y, Wang S et al (2014) Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Antivir Res 104:7\u201314. https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.011","journal-title":"Antivir Res"},{"key":"3641_CR72","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ja.2016.16","volume":"69","author":"C Mu\u00f1oz-Camargo","year":"2016","unstructured":"Mu\u00f1oz-Camargo C, M\u00e9ndez MC, Salazar V et al (2016) Frog skin cultures secrete anti-yellow fever compounds. J Antibiot (Tokyo) 69:783\u2013790. https:\/\/doi.org\/10.1038\/ja.2016.16","journal-title":"J Antibiot (Tokyo)"},{"key":"3641_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.antiviral.2016.07.004","volume":"133","author":"A Vaillant","year":"2016","unstructured":"Vaillant A (2016) Nucleic acid polymers: broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection. Antivir Res 133:32\u201340. https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.004","journal-title":"Antivir Res"},{"key":"3641_CR74","doi-asserted-by":"publisher","first-page":"9906","DOI":"10.3390\/ijms14059906","volume":"14","author":"AM Carmona-Ribeiro","year":"2013","unstructured":"Carmona-Ribeiro AM, de Melo Carrasco LD (2013) Cationic antimicrobial polymers and their assemblies. Int J Mol Sci 14:9906\u20139946. https:\/\/doi.org\/10.3390\/ijms14059906","journal-title":"Int J Mol Sci"},{"key":"3641_CR75","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.2174\/1568026616666151120113040","volume":"16","author":"YA Ivanenkov","year":"2016","unstructured":"Ivanenkov YA, Veselov MS, Shakhbazyan AG et al (2016) A comprehensive insight into the chemical space and ADME features of small molecule NS5A inhibitors. Curr Top Med Chem 16:1372\u20131382. https:\/\/doi.org\/10.2174\/1568026616666151120113040","journal-title":"Curr Top Med Chem"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-017-3641-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:41:39Z","timestamp":1684860099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-017-3641-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3641-5","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"assertion":[{"value":"8 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was funded by Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq) (UNIVERSAL 446997\/2014-5 and 449984\/2014-1) and Funda\u00e7\u00e3o de Amparo a Pesquisa de Minas Gerais (FAPEMIG) (EDITAL APQ-00557-14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors report that they do not have any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}